Benjamin Robin Schrank MD PhD
Resident at UT MD Anderson Cancer Center (Radiation Oncology)
Join to View Full Profile
MD Anderson Cancer CenterHouston, TX 77030
Dr. Schrank is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas M D Anderson Cancer CenterResidency, Radiation Oncology, 2021 - 2025
Memorial Sloan Kettering Cancer CenterInternship, Transitional Year, 2020 - 2021
Columbia University Vagelos College of Physicians and SurgeonsClass of 2020, MD, PhD
Publications & Presentations
PubMed
- An antibody-toxin conjugate targeting CD47 linked to the bacterial toxin listeriolysin O for cancer immunotherapy.Benjamin R Schrank, Yifan Wang, Annette Wu, Nhat Tran, DaeYong Lee
Nature Cancer. 2025-03-01 - Genomic Biomarkers Predict Response to Combined ATR Inhibition and Radiotherapy.Benjamin R Schrank, Lauren E Colbert
Clinical Cancer Research. 2024-12-16 - Ultra-Low-Dose Radiation for Extranodal Marginal Zone Lymphoma of the Lung.Susan Y Wu, Penny Q Fang, Ahmed Fetooh, Gohar S Manzar, Kelsey L Corrigan
Advances in Radiation Oncology. 2024-12-01
Journal Articles
- Nuclear ARP2/3 Drives DNA Break Clustering for Homology-Directed RepairBenjamin Schrank, MD, Nature
Press Mentions
Novel Antibody-Toxin Conjugate (ATC) Prompts Immune System to Eliminate TumorsFebruary 26th, 2025- MD Anderson Unveils New Antibody-Toxin ConjugateFebruary 26th, 2025
- Novel Cancer Treatment Uses Bacterial Toxin to Train Immune SystemFebruary 25th, 2025
- Join now to see all
Professional Memberships
- American Society for Radiation OncologyMember
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
